Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals's GHG Emissions Data Preview
In 2023, Recursion Pharmaceuticals completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Recursion Pharmaceuticals has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2023 | 2022 | 2021 | 2020 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy/Paste is a PRO feature.  a | Copy/Paste is a PRO feature.  | 0000000 |
Total Scope 2 | ||||
Market-Based | Copy/Paste is a PRO feature.  a | 0000000 | Copy/Paste is a PRO feature. | 0000000 |
Location-Based | Copy/Paste is a PRO feature.  a | 0000000 | Copy/Paste is a PRO feature. | 0000000 |
Total Scope 3 | Copy/Paste is a PRO feature. | Copy/Paste is a PRO feature. | 0000000 | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | 0000000 | Copy/Paste is a PRO feature.  a | Copy/Paste is a PRO feature. | 0000000 |
Verified Sources Behind Recursion Pharmaceuticals’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Recursion Pharmaceuticals’s data sources below and access millions more through our Disclosure Search.
Insights into Recursion Pharmaceuticals's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of Recursion Pharmaceuticals amounted to 2,718 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Recursion Pharmaceuticals increased by 117.61%, suggesting that the company faced challenges in reducing its emissions from its core operations.a
Recursion Pharmaceuticals's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Recursion Pharmaceuticals's Scope 1 emissions?
In 2023, the total Scope 1 emissions of Recursion Pharmaceuticals were 854 metric tons of CO₂ equivalent (tCO₂e).a
Compared to the previous year (2022), Recursion Pharmaceuticals's Scope 1 emissions increased by 217.47%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.a
What are Recursion Pharmaceuticals's Scope 2 emissions?
In 2023, Recursion Pharmaceuticals reported Scope 2 greenhouse gas (GHG) emissions of 1,474 tCO₂e using the market-based method and 1,864 tCO₂e using the location-based method.a
What methodology does Recursion Pharmaceuticals use for Scope 2 reporting?
In 2023, Recursion Pharmaceuticals reported its Scope 2 emissions using the market-based method and using the location-based method.a
Recursion Pharmaceuticals's Scope 2 Emissions Over Time
- Total Scope 2 Location-Based
- Total Scope 2 Market-Based
Insights into Recursion Pharmaceuticals’s GHG Emissions Intensity Compared to Industry Peers
In 2023, Recursion Pharmaceuticals reported Scope 1 greenhouse gas (GHG) emissions of 854 tCO₂e and total revenues of USD 44 millions. This translates into an emissions intensity of 19.46 tCO₂e per millions USD.a
Recursion Pharmaceuticals's Scope 1 Emissions Intensity Compared to Peers
How does Recursion Pharmaceuticals's GHG emissions intensity compare to its peers?
In 2023, Recursion Pharmaceuticals reported a Scope 1 emissions intensity of 19.46 tCO₂e per millions USD. Compared to the peer group median of 2.64, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a
Where does Recursion Pharmaceuticals rank on GHG emissions intensity within its industry?
In 2023, Recursion Pharmaceuticals ranked 22 out of 21 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a
This places Recursion Pharmaceuticals among the least efficient performers, with one of the highest emissions intensities in its sector.a